Clough Global Dividend and Income Fund (NYSEAMERICAN:GLV) Declares $0.06 Monthly Dividend
by Doug Wharley · The Cerbat GemClough Global Dividend and Income Fund (NYSEAMERICAN:GLV – Get Free Report) declared a monthly dividend on Thursday, January 8th. Stockholders of record on Wednesday, March 18th will be paid a dividend of 0.0566 per share by the investment management company on Tuesday, March 31st. This represents a c) annualized dividend and a dividend yield of 11.0%. The ex-dividend date of this dividend is Wednesday, March 18th.
Clough Global Dividend and Income Fund Stock Performance
Clough Global Dividend and Income Fund stock traded up $0.07 during mid-day trading on Thursday, hitting $6.15. 26,497 shares of the company’s stock were exchanged, compared to its average volume of 29,079. Clough Global Dividend and Income Fund has a fifty-two week low of $4.88 and a fifty-two week high of $6.35. The company’s 50 day simple moving average is $6.04 and its 200-day simple moving average is $5.88.
Clough Global Dividend and Income Fund Company Profile
Clough Global Dividend and Income Fund (NYSEAMERICAN: GLV) is a closed-end management investment company designed to provide investors with a combination of high current income and the potential for long-term capital appreciation. The fund pursues its objectives by investing primarily in dividend-paying equity securities of companies located throughout developed and emerging markets. In addition to its global equity allocation, Clough Global Dividend and Income Fund may allocate a portion of its assets to fixed-income instruments, including high-yield corporate bonds and preferred securities, to enhance current income potential.
Established in 2016, the fund is advised by Clough Capital Partners, L.P., an investment management firm headquartered in Greenwood Village, Colorado.
Recommended Stories
- Five stocks we like better than Clough Global Dividend and Income Fund
- A month before the crash
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- YDES Could Be 2026’s Biotech Breakthrough
- Trump’s new AI budget just passed — one stock could soar